Published in FDA Law Weekly, May 26th, 2005
The company is seeking both healthy women and those with recently diagnosed breast cancer, as well as physicians who are interested in being contacted for more information. When new studies are launched, those who sign up will be contacted first with complete study details and requirements. The studies are part of the U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) process for the BT Test. The company...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly